The average five-year survival rate for a range of childhood cancers increased from 58 percent to 81 percent between 1975 and 2005, according to statistics from the National cancer Institute.
根据美国国家癌症研究所对一系列儿童癌症患者的统计，在1975年到2005年间，平均五年存活率已经从58%上升到了81%。
The five-year survival rate, a key indicator for cancer remission, is less than 25 percent among Chinese patients. In western countries, the number is 68.
五年存活率(缓解癌症的关键指标)在中国患者身上低于25%，而在西方国家，该比例是68%。
The American cancer Society says the five-year survival rate for pancreatic cancer patients is about 5 percent.
在美国有37680名患者被查出胰腺癌，其中34290死于胰腺癌。美国癌症协会称过去5年内这种癌症病人的存活率约5%。
The average survival rate ranges from less than a year for the most advanced cancers to about five years for slower growing tumors.
平均的存活范围从大多数癌症晚期的少于一年到扩散缓慢的肿瘤的五年。
The five-year relative survival rate for people whose colorectal cancer is treated in an early stage is greater than 90 percent.
在结直肠癌早期阶段接受治疗的患者的5年相对生存率超过90%。
The five-year survival rate for melanoma is about 98 percent if detected early but can be as low as 15 percent when detected at an advanced stage.
如果诊断及时，98%的病人能够活5年以上，但如果在晚期才诊断出黑色素瘤，这个数字就降至15%。
As well, women are surviving longer: the five-year survival rate is now 86%, meaning that of all the women diagnosed with breast cancer today, 86 out of every 100 will be alive five years from now.
同时，女性存活时间更长：目前，5年的存活率为86%，这意味着，今天所有被诊断出患有乳腺癌的女性，每100名中就有86名将从现在起存活5年。
Once the cancer has spread to nearby organs or lymph nodes, the five-year relative survival rate decreases dramatically.
一旦肿瘤播散至邻近脏器或淋巴结，5年相对生存率急剧下降。
Each five-year survival rate after surgery varies depending on the nature of cancer and may be found sooner or later.
手术后五年存活率各人不一，端看肿瘤的性质及发现的早晚而定。
With current therapies of OS, such as extensive surgical excision, radiotherapy and neoadjuvant chemotherapy, five-year survival rate has increased up to 50%-60%.
随着骨肉瘤治疗手段的进展，如扩大切除术、放疗和新辅助化疗，其5年生存率已经增加到50～60%。
With current therapies of OS, such as extensive surgical excision, radiotherapy and neoadjuvant chemotherapy, five-year survival rate has increased up to 50%-60%.
随着骨肉瘤治疗手段的进展，如扩大切除术、放疗和新辅助化疗，其5年生存率已经增加到50～60%。
应用推荐